London Daily

Focus on the big picture.
Thursday, Oct 09, 2025

UK experts back AstraZeneca jab amid Germany ruling

UK experts back AstraZeneca jab amid Germany ruling

The prime minister and Public Health England have both defended the use of the Oxford-AstraZeneca jab, after Germany recommended that it should only be given to people aged under 65.

Dr Mary Ramsay of PHE said the jab offers "high levels of protection" against Covid-19, particularly against severe illness.

Boris Johnson said he was not concerned by Germany's recommendation.

AstraZeneca said the jab's trial data supported efficacy in the over-65s.

Germany's vaccine committee said the AstraZeneca vaccine should only be given to people aged under 65, citing a lack of sufficient data to recommend use among older age groups.

The European Medicines Agency (EMA) is to decide on Friday whether to approve the vaccine for use across the EU.

But Dr Ramsay, head of immunisations at Public Health England, said: "Both the AstraZeneca and Pfizer-BioNTech vaccines are safe and provide high levels of protection against Covid-19, particularly against severe disease.

"There were too few cases in older people in the AstraZeneca trials to observe precise levels of protection in this group, but data on immune responses were very reassuring."

Mr Johnson said he was not concerned by Germany's recommendation, adding that the UK's watchdog, the Medicines and Healthcare products Regulatory Agency (MHRA), had "made it very clear" that the AstraZeneca vaccine is "very good and efficacious" and gives a "high degree of protection after just one dose, and even more after two doses".

Speaking during a visit to Scotland, the prime minister added: "The evidence that they've supplied is that they think it is effective across all age groups [and] provides a good immune response across all age groups, so I don't agree with that [Germany's recommendation]."

An AstraZeneca spokesperson said the latest analyses of clinical trial data for its vaccine "support efficacy in the over 65 years age group", adding that the firm was awaiting "a regulatory decision on the vaccine by the EMA in the coming days".



All of the regulators and experts in different countries have been looking at the same data on the Oxford-AstraZeneca vaccine.

That data comes from clinical trials, and those did recruit fewer elderly people overall.

That's because they started off first with younger volunteers to get results as quickly as possible, given the urgency to find out if a vaccine would work well enough to help get us out of the pandemic.

The scientists who ran the trials have always been upfront about this.

But they say there is other evidence to suggest the vaccine will work well in older adults.

Studies show the over-65s have a strong immune responses to the vaccine. After receiving the shots their blood has plenty of the required antibodies that can fight coronavirus.

The UK has been using the AstraZeneca vaccine in its mass immunisation programme for weeks now and should soon have more proof from the real world setting about how much protection the shots give.

Prof Paul Hunter, of the University of East Anglia, told BBC News that the elderly should not worry about receiving the jab.

He said: "I'm almost 65 myself and I would happily take any of the vaccines, including the Oxford-AstraZeneca vaccine. We do know that it is safe in people over 65.

"They have much fewer side effects than younger people and it almost certainly provides substantial benefits in terms of preventing severe disease and reducing the chances of going into hospital."

'No concerns' over safety


Prof Adam Finn, a member of the Joint Committee on Vaccination and Immunisation (JCVI), told BBC's Radio 4's PM programme that Germany's recommendation "just reflects different levels of caution", adding: "What they are basically doing is saying 'We'd like to wait a big longer and know a bit more before we move."

Prof Finn, professor of paediatrics at the University of Bristol, said: "We have no concerns about the safety of the vaccine in any age group".

Dr Doug Brown, chief executive of the British Society for Immunology, said the MHRA would have "carefully scrutinised the evidence" on the AstraZeneca jab before making their recommendation, and referred to its original report which stated that there is "there is limited information available on efficacy in participants aged 65 or over, although there is nothing to suggest lack of protection".

He said this reflected a "need for more data" on the effectiveness of the jab in this age group, but noted the jab had shown a "good safety profile" in all published reports.

Prof Jim Naismith, director of the Rosalind Franklin Institute at the University of Oxford, said German scientists had "not said the vaccine is ineffective for over-65s".

He added: "Scientists often disagree about how much evidence is needed for any new advance and there is always more data to be secured.

"Normally this all happens out of sight of the glare of the media and not in a pandemic, but such debates are an important part of the scientific process that is familiar to anyone who has ever been through peer review."



Meanwhile, the EU and AstraZeneca are involved in a row over vaccine supply shortages.

AstraZeneca has previously said it could deliver only a fraction of the doses between January and March that it had promised to the bloc, blaming production issues at EU plants for a reported 50 million-dose shortfall.

The EU has demanded that UK-made jabs are diverted to mainland Europe to fulfil contractual obligations.

However, both sides pledged to work together to resolve the crisis.

But Cabinet Office minister Michael Gove has said there would "be no interruption" to UK vaccine supplies.

It comes as the UK recorded a further 1,239 deaths within 28 days of a positive coronavirus test on Thursday, according to government figures. There have also been another 28,680 new infections.


How does a vaccine get approved?


Newsletter

Related Articles

0:00
0:00
Close
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
×